Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2015 (2015), Article ID 938305, 6 pages
http://dx.doi.org/10.1155/2015/938305
Research Article

Subclassification of Follicular Neoplasms Recommended by the Japan Thyroid Association Reporting System of Thyroid Cytology

1Department of Pathology, Nara Hospital, Kinki University Faculty of Medicine, Otoda-cho 1248-1, Ikoma, Nara 630-0293, Japan
2Division of Diagnostic Pathology, Keio University School of Medicine, Tokyo 160-8582, Japan
3Department of Pathology, Kuma Hospital, Kobe 650-0011, Japan
4Department of Human Pathology, Yamanashi University School of Medicine, Yamanashi 409-3898, Japan
5Department of Internal Medicine, Kuma Hospital, Kobe 650-0011, Japan

Received 27 November 2014; Revised 17 January 2015; Accepted 18 January 2015

Academic Editor: Mario Maggi

Copyright © 2015 Kennichi Kakudo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Z. W. Baloch, V. A. LiVolsi, S. L. Asa et al., “Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the national cancer institute thyroid fine-needle aspiration state of the science conference,” Diagnostic Cytopathology, vol. 36, no. 6, pp. 425–437, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Z. Ali and E. S. Cibas, The Bethesda System for Reporting Thyroid Cytopathology. Definitions, Criteria and Explanatory Notes, Springer, New York, NY, USA, 2009.
  3. G. Kocjan, B. Cochand-Priollet, P. P. De Agustin et al., “Diagnostic terminology for reporting thyroid fine needle aspiration cytology: European Federation of Cytology Societies thyroid working party symposium, Lisbon 2009,” Cytopathology, vol. 21, no. 2, pp. 86–92, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Lobo, A. McQueen, T. Beale, and G. Kocjan, “The UK royal college of pathologists thyroid fine-needle aspiration diagnostic classification is a robust tool for the clinical management of abnormal thyroid nodules,” Acta Cytologica, vol. 55, no. 6, pp. 499–506, 2010. View at Google Scholar
  5. G. Fadda, F. Basolo, A. Bondi et al., “Cytological classification of thyroid nodules. Proposal of the SIAPEC-IAP Italian consensus working group,” Pathologica, vol. 102, no. 5, pp. 405–408, 2010. View at Google Scholar · View at Scopus
  6. F. Nardi, F. Basolo, A. Crescenzi et al., “Italian consensus for the classification and reporting of thyroid cytology,” Journal of Endocrinological Investigation, vol. 37, no. 6, pp. 593–599, 2014. View at Publisher · View at Google Scholar
  7. The Japan Thyroid Association, Guidelines for Clinical Practice for the Management of Thyroid Nodules in Japan 2013, Nankod, Tokyo, Japan, 2013, (Japanese).
  8. K. Kakudo, K. Kameyama, A. Miyauchi, and H. Nakamura, “Introducing the reporting system for thyroid fine-needle aspiration cytology according to the new guidelines of the Japan Thyroid Association,” Endocrine Journal, vol. 61, no. 6, pp. 539–552, 2014. View at Publisher · View at Google Scholar
  9. K. Kakudo, K. Kameyama, and A. Miyauchi, “History of thyroid cytology in Japan and reporting system recommended by the Japan Thyroid Association,” Journal of Basic & Clinical Medicine, vol. 2, no. 2, pp. 10–15, 2013, http://sspublications.org/index.php/JBCM/article/view/30/26. View at Google Scholar
  10. “Guidelines of the Papanicolaou Society of Cytopathology for the examination of fine-needle aspiration specimens from thyroid nodules. The Papanicolaou Society of Cytopathology Task Force,” Diagnostic Cytopathology, vol. 15, no. 1, pp. 84–89, 1996. View at Publisher · View at Google Scholar
  11. J. A. Cohen, “A coefficient of agreement for nominal scales,” Educational and Psychological Measurement, vol. 20, pp. 37–46, 1960. View at Publisher · View at Google Scholar
  12. J. L. Fleiss, “Measuring nominal scale agreement among many raters,” Psychological Bulletin, vol. 76, no. 2, pp. 378–382, 1971. View at Google Scholar · View at Scopus
  13. M. Kihara, M. Hirokawa, Y. Ito, K. Kobayashi, A. Miya, and A. Miyauchi, “Final pathology findings after immediate or delayed surgery in patients with cytologically benign or follicular thyroid nodules,” World Journal of Surgery, vol. 35, no. 3, pp. 558–562, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Kihara, Y. Ito, M. Hirokawa et al., “Role of ultrasonography in patients with cytologically follicular thyroid tumor,” Auris Nasus Larynx, vol. 38, no. 4, pp. 508–511, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Takezawa, A. Sakamoto, K. Komatsu et al., “Cytological evaluation of the ‘Indeterminate’ category by the Bethesda system for reporting thyroid cytopathology,” The Journal of the Japanese Society of Clinical Cytology, vol. 53, no. 4, pp. 251–256, 2014 (Japanese). View at Publisher · View at Google Scholar
  16. K. Sugino, K. Ito, T. Mimura et al., “The enucleation of thyroid tumors indeterminate before surgery as papillary thyroid carcinoma: should immediate reoperation be performed?” Surgery Today, vol. 24, no. 4, pp. 305–308, 1994. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Ito, T. Higashiyama, Y. Takamura et al., “Long-term follow-up for patients with papillary thyroid carcinoma treated as benign nodules,” Anticancer Research, vol. 27, no. 2, pp. 1039–1043, 2007. View at Google Scholar · View at Scopus
  18. K. Nishigami, Z. Liu, E. Taniguchi et al., “Cytological features of well-differentiated tumors of uncertain malignant potential: indeterminate cytology and WDT-UMP,” Endocrine Journal, vol. 59, no. 6, pp. 483–487, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. P. A. VanderLaan, E. Marqusee, and J. F. Krane, “Features associated with locoregional spread of papillary carcinoma correlate with diagnostic category in the bethesda system for reporting thyroid cytopathology,” Cancer Cytopathology, vol. 120, no. 4, pp. 245–253, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Rago, M. Scutari, F. Latrofa et al., “The large majority of 1520 patients with indeterminate thyroid nodule at cytology have a favorable outcome, and a clinical risk score has a high negative predictive value for a more cumbersome cancer disease,” The Journal of Clinical Endocrinology & Metabolism, vol. 99, no. 10, pp. 3700–3707, 2014. View at Publisher · View at Google Scholar
  21. E. S. Cibas, Z. W. Baloch, G. Fellegara et al., “A prospective assessment defining the limitations of thyroid nodule pathologic evaluation,” Annals of Internal Medicine, vol. 159, no. 5, pp. 325–332, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. N. P. Ohori and K. E. Schoedel, “Variability in the atypia of undetermined significance/follicular lesion of undetermined significance diagnosis in the Bethesda system for reporting thyroid cytopathology: sources and recommendations,” Acta Cytologica, vol. 55, no. 6, pp. 492–498, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. A. S. Ho, E. E. Sarti, K. S. Jain et al., “Malignancy rate in thyroid nodules classified as bethesda category III (AUS/FLUS),” Thyroid, vol. 24, no. 5, pp. 832–839, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Crippa and R. Dina, “Interobserver reproducibility of thyroid fine-needle aspiration using the UK Royal College of Pathologists' classification system,” American Journal of Clinical Pathology, vol. 137, no. 5, pp. 833–835, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Akhtar and M. S. Awan, “Role of fine needle aspiration and frozen section in determining the extent of thyroidectomy,” European Archives of Oto-Rhino-Laryngology, vol. 264, no. 9, pp. 1075–1079, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Saiegh, C. Shechner, G. Dickstein et al., “Role of cytological and ultrasonographic features in predicting the risk of malignancy in thyroid nodules with indeterminate cytology,” Minerva Endocrinologica, vol. 39, no. 1, pp. 43–52, 2014. View at Google Scholar · View at Scopus
  27. J. H. Yoon, E.-K. Kim, J. H. Youk, H. J. Moon, and J. Y. Kwak, “Better understanding in the differentiation of thyroid follicular adenoma, follicular carcinoma, and follicular variant of papillary carcinoma: a retrospective study,” International Journal of Endocrinology, vol. 2014, Article ID 321595, 9 pages, 2014. View at Publisher · View at Google Scholar
  28. A. S. Kelman, A. Rathan, J. Leibowitz, D. E. Burstein, and R. S. Haber, “Thyroid cytology and the risk of malignancy in thyroid nodules: importance of nuclear atypia in indeterminate specimens,” Thyroid, vol. 11, no. 3, pp. 271–277, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. R. E. Goldstein, J. L. Netterville, B. Burkey, and J. E. Johnson, “Implications of follicular neoplasms, atypia, and lesions suspicious for malignancy diagnosed by fine-needle aspiration of thyroid nodules,” Annals of Surgery, vol. 235, no. 5, pp. 656–664, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Pagni, M. Prada, P. Goffredo et al., “‘Indeterminate for malignancy’ (Tir3/Thy3 in the Italian and British systems for classification) thyroid fine needle aspiration (FNA) cytology reporting: morphological criteria and clinical impact,” Cytopathology, vol. 25, no. 3, pp. 170–176, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Sahin, A. Gursoy, N. B. Tutuncu, and D. N. Guvener, “Prevalence and prediction of malignancy in cytologically indeterminate thyroid nodules,” Clinical Endocrinology, vol. 65, no. 4, pp. 514–518, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. M. D. Williams, J. W. Suliburk, G. A. Staerkel et al., “Clinical significance of distinguishing between follicular lesion and follicular neoplasm in thyroid fine-needle aspiration biopsy,” Annals of Surgical Oncology, vol. 16, no. 11, pp. 3146–3153, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Barbaro, U. Simi, P. Lopane et al., “Thyroid nodules with microfollicular findings reported on fine-needle aspiration: invariably surgical treatment?” Endocrine Practice, vol. 7, no. 5, pp. 352–357, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Ustun, D. Chhieng, A. Van Dyke et al., “Risk stratification in follicular neoplasm: a cytological assessment using modified Bethesda classification,” Cancer Cytopathology, vol. 122, no. 7, pp. 536–545, 2014. View at Publisher · View at Google Scholar
  35. R. Gerhard and G. da Cunha Santos, “Inter- and intraobserver reproducibility of thyroid fine needle aspiration cytology: an analysis of discrepant cases,” Cytopathology, vol. 18, no. 2, pp. 105–111, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Kocjan, A. Chandra, P. A. Cross et al., “The interobserver reproducibility of thyroid fine-needle aspiration using the UK Royal College of pathologists' classification system,” American Journal of Clinical Pathology, vol. 135, no. 6, pp. 852–859, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. J. S. Abele and R. A. Levine, “Diagnostic criteria and risk-adapted approach to indeterminate thyroid cytodiagnosis,” Cancer Cytopathology, vol. 118, no. 6, pp. 415–422, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. K. M. Clary, J. L. Condel, Y. Liu, D. R. Johnson, D. M. Grzybicki, and S. S. Raab, “Interobserver variability in the fine needle aspiration biopsy diagnosis of follicular lesions of the thyroid gland,” Acta Cytologica, vol. 49, no. 4, pp. 378–382, 2005. View at Publisher · View at Google Scholar · View at Scopus